Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexalin Technology (NXL) Common Equity (2021 - 2025)

Nexalin Technology (NXL) has 5 years of Common Equity data on record, last reported at $4.8 million in Q3 2025.

  • For Q3 2025, Common Equity fell 3.82% year-over-year to $4.8 million; the TTM value through Sep 2025 reached $4.8 million, down 3.82%, while the annual FY2024 figure was $3.7 million, 14.64% up from the prior year.
  • Common Equity reached $4.8 million in Q3 2025 per NXL's latest filing, down from $6.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $6.4 million in Q3 2022 and bottomed at -$2.2 million in Q2 2022.
  • Average Common Equity over 5 years is $2.6 million, with a median of $3.2 million recorded in 2023.
  • Peak YoY movement for Common Equity: surged 425.74% in 2022, then plummeted 66.17% in 2024.
  • A 5-year view of Common Equity shows it stood at -$1.7 million in 2021, then soared by 425.74% to $5.5 million in 2022, then tumbled by 41.47% to $3.2 million in 2023, then grew by 14.64% to $3.7 million in 2024, then grew by 29.72% to $4.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $4.8 million in Q3 2025, $6.0 million in Q2 2025, and $2.3 million in Q1 2025.